Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Planning your retirement portfolio at 40? Discover essential assets to include for a balanced and secure financial future.
20,511 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
As June begins, NVIDIA has surged to the top of investor lists as the biggest June bet on AI infrastructure, backed b...
AI-led tech names lead a Nasdaq rebound as volatility subsides and oil prices pull back. Here are the latest numbers,...
Bitcoin steadies around the $63,000 mark as investors weigh how quantum computing could shake traditional banking cry...
Unlock Technologies announced the closing of a $358.5 million home equity agreement securitization, the largest HEA d...
SpaceX's move toward a public market future brings questions about lockups. This guide explains spacex lockup period:...
South Florida's investment map is shifting as Griffin expands in Miami and Stephen Ross grows in West Palm Beach, red...
Stocks drift lower in mid-June 2026 as investors reassess AI and chip names. This guide lays out what look when buyin...
Two AI models weigh in on whether SpaceX’s high-profile IPO will boost or drag Bitcoin in the near term. The verdict ...
Insider moves always spark questions. This article unpacks EverCommerce's sells 19,200 shares, what it signals, and h...
As AI excitement cools, investors parse the shift from trade short-term bets to a lasting investment decade. BlackRoc...
As June 2026 markets churn, traders are weighing ETHT, a 2x Ether futures ETF, against ETHA, a spot Ether trust, amid...